These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6968090)

  • 1. A two-signal mechanism for the induction of cytotoxic T lymphocytes.
    Symington FW; Teh HS
    Scand J Immunol; 1980; 12(1):1-12. PubMed ID: 6968090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of cytotoxic lymphocyte responses in vitro by soluble products of alloantigen-activated spleen cells.
    Truitt GA; Rich RR; Rich SS
    J Immunol; 1978 Sep; 121(3):1045-51. PubMed ID: 151115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-presenting T cells. I. Class I alloantigen (bm1)-bearing T lymphoblasts efficiently stimulate a primary clonal response of Lyt-2+ cytotoxic lymphocyte precursors of B6 origin.
    Reimann J; Bellan A; Kabelitz D
    J Immunol; 1987 Feb; 138(4):1042-50. PubMed ID: 3492539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of alloantigen-induced cytotoxic responses by concanavalin A-activated lymphoid cells: suppression by antigen elimination.
    Kastner DL; Rich RR
    J Immunol; 1978 Nov; 121(5):1732-7. PubMed ID: 712063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative studies on the precursors of cytotoxic lymphocytes. II. Specificity of precursors responsive to alloantigens and to concanavalin A.
    Teh HS; Phillips RA; Miller RG
    J Immunol; 1977 Mar; 118(3):1057-62. PubMed ID: 66268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of costimulator on immune responses in vitro.
    Shaw J; Monticone V; Mills G; Paetkau V
    J Immunol; 1978 Jun; 120(6):1974-80. PubMed ID: 149174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of in vitro cytotoxic T lymphocyte generation. II. Demonstration of noncytotoxic alloantigen-specific suppressor T lymphocytes.
    Schwartz A; Sutton SL; Gershon RK
    Eur J Immunol; 1982 May; 12(5):380-6. PubMed ID: 6212258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytotoxic lymphocytes. IV. Frequency and clonal specificity of CD8+CD16-(Leu2+Leu11-) and CD16+CD3-(Leu11+Leu4-) cytotoxic lymphocyte precursors activated by alloantigen or K562 stimulator cells.
    Kabelitz D
    Cell Immunol; 1989 Jul; 121(2):298-305. PubMed ID: 2525425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of nonspecific killer cells by interleukin 2-containing supernatants.
    Teh HS; Yu M
    J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
    J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
    Giovarelli M; Santoni A; Forni G
    J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct evidence for a two-signal mechanism of cytotoxic T-lymphocyte activation.
    Teh HS; Teh SJ
    Nature; 1980 May; 285(5761):163-5. PubMed ID: 6966377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2).
    Mills GB; Paetkau V
    J Immunol; 1980 Nov; 125(5):1897-903. PubMed ID: 6159395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
    Isakov N; Altman A
    J Immunol; 1985 Dec; 135(6):3674-80. PubMed ID: 2999231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of allogeneic and self-restricted stimulation of lymphokine production by dual-reactive cloned T cells.
    Wilde DB; Prystowsky MB; Beller DI; Goldwasser E; Ihle JN; Vogel SN; Fitch FW
    J Immunol; 1984 Oct; 133(4):1992-5. PubMed ID: 6206145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The xenogeneic effect. III. Induction of cell-mediated cytotoxicity by alloantigen-stimulated thymocytes in the presence of xenogeneic reconstitution factor.
    Simon PL; Farrar JJ; Kind PD
    J Immunol; 1977 Apr; 118(4):1129-31. PubMed ID: 66277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 2 production by alloantigen (H-2) activated T cells.
    Andrus L; Lafferty KJ
    Aust J Exp Biol Med Sci; 1981 Aug; 59(4):413-26. PubMed ID: 6975098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.